Literature DB >> 24446722

Multiple highly and moderately differentiated squamous cell carcinomas of the skin during vismodegib treatment of inoperable basal cell carcinoma.

A Orouji1, S Goerdt, J Utikal, M Leverkus.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24446722     DOI: 10.1111/bjd.12840

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  10 in total

1.  Genetic Mutations Underlying Phenotypic Plasticity in Basosquamous Carcinoma.

Authors:  Audris Chiang; Caroline Z Tan; François Kuonen; Luqman M Hodgkinson; Felicia Chiang; Raymond J Cho; Andrew P South; Jean Y Tang; Anne Lynn S Chang; Kerri E Rieger; Anthony E Oro; Kavita Y Sarin
Journal:  J Invest Dermatol       Date:  2019-06-15       Impact factor: 8.551

2.  YAP-TEAD signaling promotes basal cell carcinoma development via a c-JUN/AP1 axis.

Authors:  Dejan Maglic; Karin Schlegelmilch; Antonella Fm Dost; Riccardo Panero; Michael T Dill; Raffaele A Calogero; Fernando D Camargo
Journal:  EMBO J       Date:  2018-07-23       Impact factor: 11.598

3.  Aggressive basal cell carcinoma of the head and neck: challenges in surgical management.

Authors:  Peter J F M Lohuis; Anil Joshi; Pepijn A Borggreven; Lenka Vermeeren; Biljana Zupan-Kajcovski; Abrahim Al-Mamgani; Alfons J M Balm
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-04-11       Impact factor: 2.503

Review 4.  Genetic and environmental factors underlying keratinocyte carcinoma risk.

Authors:  Hélène Choquet; Sepideh Ashrafzadeh; Yuhree Kim; Maryam M Asgari; Eric Jorgenson
Journal:  JCI Insight       Date:  2020-05-21

5.  Dissecting Genomic Aberrations in Myeloproliferative Neoplasms by Multiplex-PCR and Next Generation Sequencing.

Authors:  Martin M J Kirschner; Mirle Schemionek; Claudia Schubert; Nicolas Chatain; Stephanie Sontag; Susanne Isfort; Nadina Ortiz-Brüchle; Karla Schmitt; Luisa Krüger; Klaus Zerres; Martin Zenke; Tim H Brümmendorf; Steffen Koschmieder
Journal:  PLoS One       Date:  2015-04-20       Impact factor: 3.240

6.  Spreading of Isolated Ptch Mutant Basal Cell Carcinoma Precursors Is Physiologically Suppressed and Counteracts Tumor Formation in Mice.

Authors:  Nadine Brandes; Slavica Hristomanova Mitkovska; Dominik Simon Botermann; Wiebke Maurer; Anna Müllen; Hanna Scheile; Sebastian Zabel; Anke Frommhold; Ina Heß; Heidi Hahn; Anja Uhmann
Journal:  Int J Mol Sci       Date:  2020-12-05       Impact factor: 5.923

7.  Metastatic same-site squamous cell carcinoma arising during vismodegib therapy for basal cell carcinoma.

Authors:  Raymond Zhao; Bo Wang; Lori Lowe; Andrzej Dlugosz; Christopher K Bichakjian
Journal:  JAAD Case Rep       Date:  2022-08-10

8.  Combination Trimodality Therapy Using Vismodegib for Basal Cell Carcinoma of the Face.

Authors:  Alec M Block; Fiori Alite; Aidnag Z Diaz; Richard W Borrowdale; Joseph I Clark; Mehee Choi
Journal:  Case Rep Oncol Med       Date:  2015-10-04

Review 9.  Advanced basal cell carcinoma, the hedgehog pathway, and treatment options - role of smoothened inhibitors.

Authors:  Leslie A Fecher; William H Sharfman
Journal:  Biologics       Date:  2015-11-06

Review 10.  Chimeric Monoclonal Antibody Cetuximab Targeting Epidermal Growth Factor-Receptor in Advanced Non-Melanoma Skin Cancer.

Authors:  Uwe Wollina; Georgi Tchernev; Torello Lotti
Journal:  Open Access Maced J Med Sci       Date:  2017-12-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.